Literature DB >> 27742872

Contrast-enhanced ultrasound does not discriminate between community acquired pneumonia and lung cancer.

Marco Sperandeo1, Gaetano Rea2, Maria Arcangela Grimaldi3, Francesca Trovato4, Lucia M C Dimitri5, Vincenzo Carnevale3.   

Abstract

We investigated if contrast-enhanced ultrasound (CEUS) may differentiate community acquired pneumonia (CAP) from lung cancer (LC). Among 1374 patients admitted in a 5-year period for lung opacities, 728 (329 CAP and 399 LC) were investigated by CEUS, comparing the time of appearance, disappearance, duration and pattern of distribution of contrast enhancement (CE). The patients with CAP and LC did not differ in terms of age, time of CE appearance, disappearance and duration or CE distribution. Our data show that the timing and pattern of CE detected by chest CEUS does not distinguish between CAP and LC and overly optimistic beliefs on this matter should be abandoned. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Imaging/CT MRI etc; Lung Cancer; Pneumonia

Mesh:

Substances:

Year:  2016        PMID: 27742872     DOI: 10.1136/thoraxjnl-2016-208913

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  8 in total

1.  Lung Ultrasound: The Essentials.

Authors:  Thomas J Marini; Deborah J Rubens; Yu T Zhao; Justin Weis; Timothy P O'Connor; William H Novak; Katherine A Kaproth-Joslin
Journal:  Radiol Cardiothorac Imaging       Date:  2021-04-29

2.  Emergency thoracic ultrasound and clinical risk management.

Authors:  Maria Concetta Interrigi; Francesca M Trovato; Daniela Catalano; Guglielmo M Trovato
Journal:  Ther Clin Risk Manag       Date:  2017-02-09       Impact factor: 2.423

3.  Ultrasound-Guided Biopsy of Pleural-Based Pulmonary Lesions by Injection of Contrast-Enhancing Drugs.

Authors:  Ying Fu; Yuan-Yuan Zhang; Li-Gang Cui; Shi Tan; Yan Sun
Journal:  Front Pharmacol       Date:  2019-09-03       Impact factor: 5.810

4.  Time Difference of Arrival on Contrast-Enhanced Ultrasound in Distinguishing Benign Inflammation From Malignant Peripheral Pulmonary Lesions.

Authors:  Min Tang; Qianrong Xie; Jiasi Wang; Xiaoyu Zhai; Hong Lin; Xiaoxue Zheng; Guoli Wei; Yan Tang; Fanwei Zeng; Yanpeng Chu; Jianqiong Song; Jianqiang Cai; Fanxin Zeng
Journal:  Front Oncol       Date:  2020-11-12       Impact factor: 6.244

5.  Contrast-Enhanced Ultrasound Evaluation of Mifepristone for Treatment of Low-Risk Cesarean Scar Pregnancy.

Authors:  Xi Xiong; Chun-Yan Gao; De-Mei Ying; Ping Yan; Zhi-Jia Zhang; Na Kuang; Hong-Ju Tian; Li Luo; Shu-Yu Long; Zheng-Qiong Chen
Journal:  Contrast Media Mol Imaging       Date:  2020-10-31       Impact factor: 3.161

6.  Artificial Intelligence (AI) and Lung Ultrasound in Infectious Pulmonary Disease.

Authors:  Guglielmo Trovato; Matteo Russo
Journal:  Front Med (Lausanne)       Date:  2021-11-25

7.  Contrast-Enhanced Ultrasound Improves the Pathological Outcomes of US-Guided Core Needle Biopsy That Targets the Viable Area of Anterior Mediastinal Masses.

Authors:  Jian-Hua Zhou; Hong-Bo Shan; Wei Ou; Yun-Xian Mo; Jin Xiang; Yu Wang; Jian Li; Si-Yu Wang
Journal:  Biomed Res Int       Date:  2018-01-18       Impact factor: 3.411

Review 8.  Contrast-enhanced ultrasound of pediatric lungs.

Authors:  Vasileios Rafailidis; Savvas Andronikou; Hans-Joachim Mentzel; Maciej Piskunowicz; Judy H Squires; Carol E Barnewolt
Journal:  Pediatr Radiol       Date:  2021-05-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.